| (R)-noradrenaline | multiple interactions | ISO | RGD:732932 | 6480464 | SLC6A4 protein promotes the reaction [Norepinephrine results in increased activity of TAAR1 protein] | CTD | PMID:17234900 |
| (S)-amphetamine | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 gene polymorphism affects the susceptibility to Dextroamphetamine | CTD | PMID:16966188 |
| (S)-fenfluramine | affects activity | ISO | RGD:11314 | 6480464 | Dexfenfluramine affects the activity of SLC6A4 protein | CTD | PMID:18506000 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of SLC6A4 mRNA | CTD | PMID:16079270 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Sertraline] affects the expression of SLC6A4 mRNA; more ... | CTD | PMID:18650020 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC6A4 mRNA | CTD | PMID:21382399 PMID:18650020 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC6A4 mRNA | CTD | PMID:18650020 PMID:21382399 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Fluoxetine] results in increased expression of SLC6A4 mRNA | CTD | PMID:21382399 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC6A4 mRNA | CTD | PMID:18650020 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:732932 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SLC6A4 mRNA | CTD | PMID:23146750 |
| 2-phenylethylamine | multiple interactions | ISO | RGD:732932 | 6480464 | SLC6A4 protein promotes the reaction [phenethylamine results in increased activity of TAAR1 protein] | CTD | PMID:17234900 |
| 3,4-methylenedioxymethamphetamine | affects expression | ISO | RGD:732932 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine affects the expression of SLC6A4 protein | CTD | PMID:20483717 |
| 3,4-methylenedioxymethamphetamine | affects binding | ISO | RGD:732932 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine binds to SLC6A4 protein | CTD | PMID:16272152 |
| 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC6A4 mRNA | CTD | PMID:16054768 PMID:16489401 |
| 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC6A4 protein | CTD | PMID:16054768 |
| 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC6A4 mRNA | CTD | PMID:16489401 PMID:16054768 |
| 3,4-methylenedioxymethamphetamine | multiple interactions | ISO | RGD:732932 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine affects the reaction [N,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine binds to SLC6A4 protein] | CTD | PMID:20483717 |
| 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:732932 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC6A4 protein | CTD | PMID:18661256 |
| alendronic acid | affects expression | EXP | | 6480464 | Alendronate affects the expression of SLC6A4 mRNA | CTD | PMID:16079270 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLC6A4 mRNA | CTD | PMID:16483693 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of SLC6A4 mRNA | CTD | PMID:18315880 |
| bisphenol A | increases expression | ISO | RGD:732932 | 6480464 | bisphenol A results in increased expression of SLC6A4 mRNA | CTD | PMID:23146750 |
| cadmium atom | affects binding | ISO | RGD:732932 | 6480464 | Cadmium binds to SLC6A4 protein mutant form | CTD | PMID:16272152 |
| carbonyl sulfide | decreases expression | EXP | | 6480464 | carbonyl sulfide results in decreased expression of SLC6A4 mRNA | CTD | PMID:19395590 |
| chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of SLC6A4 | CTD | PMID:17035140 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of SLC6A4 | CTD | PMID:17035140 |
| chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of SLC6A4 mRNA | CTD | PMID:18835401 |
| citalopram | multiple interactions | ISO | RGD:732932 | 6480464 | Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| citalopram | multiple interactions | ISO | RGD:732932 | 6480464 | Citalopram binds to and results in decreased activity of SLC6A4 protein | CTD | PMID:16272152 |
| citalopram | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 promoter polymorphism affects the susceptibility to Citalopram | CTD | PMID:14624186 |
| citalopram | multiple interactions | ISO | RGD:732932 | 6480464 | SLC6A4 polymorphism inhibits the reaction [Citalopram affects the secretion of PRL protein] | CTD | PMID:17000009 |
| clomipramine | multiple interactions | ISO | RGD:732932 | 6480464 | SLC6A4 polymorphism inhibits the reaction [Clomipramine affects the secretion of PRL protein] | CTD | PMID:17000009 |
| clomipramine | multiple interactions | ISO | RGD:732932 | 6480464 | Clomipramine binds to and results in decreased activity of SLC6A4 protein | CTD | PMID:16272152 |
| clozapine | multiple interactions | ISO | RGD:732932 | 6480464 | [SLC6A4 gene polymorphism results in decreased uptake of Serotonin] which results in decreased susceptibility to Clozapine | CTD | PMID:20452607 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of SLC6A4 | CTD | PMID:12007678 |
| clozapine | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 protein affects the susceptibility to Clozapine | CTD | PMID:20452607 |
| cocaine | increases expression | ISO | RGD:732932 | 6480464 | Cocaine results in increased expression of SLC6A4 protein | CTD | PMID:11207425 |
| cocaine | multiple interactions | ISO | RGD:732932 | 6480464 | Cocaine binds to and results in decreased activity of SLC6A4 protein | CTD | PMID:16272152 |
| cocaine | decreases response to substance | EXP | | 6480464 | SLC6A4 results in decreased susceptibility to Cocaine | CTD | PMID:18581099 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of SLC6A4 mRNA | CTD | PMID:11072100 |
| cocaine | increases response to substance | EXP | | 6480464 | SLC6A4 gene mutant form results in increased susceptibility to Cocaine | CTD | PMID:20459657 |
| cocaine | affects response to substance | ISO | RGD:11314 | 6480464 | SLC6A4 mutant form affects the susceptibility to Cocaine | CTD | PMID:11320258 |
| cocaine | decreases activity | ISO | RGD:732932 | 6480464 | Cocaine results in decreased activity of SLC6A4 protein | CTD | PMID:18321529 |
| copper(2+) sulfate | decreases expression | ISO | RGD:732932 | 6480464 | Copper Sulfate results in decreased expression of SLC6A4 mRNA | CTD | PMID:19549813 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of SLC6A4 protein | CTD | PMID:16160705 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of SLC6A4 mRNA | CTD | PMID:18835401 |
| diazinon | increases expression | EXP | | 6480464 | Diazinon results in increased expression of SLC6A4 protein | CTD | PMID:17035140 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of SLC6A4 protein | CTD | PMID:17035140 |
| dieldrin | decreases expression | EXP | | 6480464 | Dieldrin results in decreased expression of SLC6A4 mRNA | CTD | PMID:18835401 |
| dopamine | multiple interactions | ISO | RGD:732932 | 6480464 | Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| fluoxetine | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 affects the susceptibility to Fluoxetine | CTD | PMID:14573314 |
| fluoxetine | decreases activity | ISO | RGD:11314 | 6480464 | Fluoxetine results in decreased activity of SLC6A4 protein | CTD | PMID:19616025 |
| fluoxetine | decreases response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 gene polymorphism results in decreased susceptibility to Fluoxetine | CTD | PMID:14604448 |
| fluoxetine | increases response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 protein results in increased susceptibility to Fluoxetine | CTD | PMID:14604448 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of SLC6A4 mRNA | CTD | PMID:15936043 more ... |
| fluoxetine | affects expression | ISO | RGD:732932 | 6480464 | Fluoxetine affects the expression of SLC6A4 protein | CTD | PMID:16951736 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of SLC6A4 mRNA | CTD | PMID:21554931 more ... |
| fluoxetine | multiple interactions | ISO | RGD:732932 | 6480464 | Fluoxetine binds to and results in decreased activity of SLC6A4 protein | CTD | PMID:16272152 |
| fluoxetine | multiple interactions | EXP | | 6480464 | [Fluoxetine results in decreased expression of SLC6A4 mRNA] which results in decreased abundance of Serotonin | CTD | PMID:16982082 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of SLC6A4 protein | CTD | PMID:18496518 |
| fluoxetine | multiple interactions | EXP | | 6480464 | Org 34850 promotes the reaction [Fluoxetine results in decreased expression of SLC6A4 protein] | CTD | PMID:18496518 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of SLC6A4 mRNA | CTD | PMID:16982082 more ... |
| fluoxetine | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 protein affects the susceptibility to Fluoxetine | CTD | PMID:20010449 |
| fluoxetine | increases response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 gene polymorphism results in increased susceptibility to Fluoxetine | CTD | PMID:20010449 |
| fluoxetine | decreases localization | ISO | RGD:732932 | 6480464 | Fluoxetine results in decreased localization of SLC6A4 protein | CTD | PMID:17289086 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of SLC6A4 mRNA | CTD | PMID:21554931 PMID:21740920 |
| fluoxetine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Fluoxetine] results in increased expression of SLC6A4 mRNA | CTD | PMID:21382399 |
| fluoxetine | increases expression | ISO | RGD:11314 | 6480464 | Fluoxetine results in increased expression of SLC6A4 mRNA | CTD | PMID:21083617 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of SLC6A4 | CTD | PMID:12007678 |
| hydrogen peroxide | affects expression | ISO | RGD:732932 | 6480464 | Hydrogen Peroxide affects the expression of SLC6A4 mRNA | CTD | PMID:20044591 |
| ketanserin | affects binding | ISO | RGD:11314 | 6480464 | Ketanserin binds to SLC6A4 protein | CTD | PMID:21871486 |
| ketanserin | multiple interactions | ISO | RGD:11314 | 6480464 | methamidophos inhibits the reaction [Ketanserin binds to SLC6A4 protein] | CTD | PMID:21871486 |
| lamivudine | multiple interactions | ISO | RGD:732932 | 6480464 | [Lamivudine co-treated with IFNA2 protein] results in increased expression of SLC6A4 mRNA; more ... | CTD | PMID:16476009 |
| lamivudine | increases expression | ISO | RGD:732932 | 6480464 | Lamivudine results in increased expression of SLC6A4 mRNA | CTD | PMID:16476009 |
| mepyramine | affects binding | ISO | RGD:732932 | 6480464 | Pyrilamine analog binds to SLC6A4 protein | CTD | PMID:11931612 |
| mercury atom | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 promoter polymorphism affects the susceptibility to Mercury | CTD | PMID:20526950 |
| mercury(0) | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 promoter polymorphism affects the susceptibility to Mercury | CTD | PMID:20526950 |
| methamidophos | multiple interactions | ISO | RGD:11314 | 6480464 | methamidophos inhibits the reaction [Ketanserin binds to SLC6A4 protein] | CTD | PMID:21871486 |
| methamphetamine | multiple interactions | ISO | RGD:732932 | 6480464 | indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| methamphetamine | affects expression | ISO | RGD:11314 | 6480464 | Methamphetamine affects the expression of SLC6A4 protein | CTD | PMID:9369336 PMID:11093760 |
| methamphetamine | decreases expression | ISO | RGD:732932 | 6480464 | Methamphetamine results in decreased expression of SLC6A4 protein | CTD | PMID:18841348 PMID:16389202 |
| methamphetamine | increases response to substance | EXP | | 6480464 | SLC6A4 protein results in increased susceptibility to Methamphetamine | CTD | PMID:10684896 |
| methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of SLC6A4 protein | CTD | PMID:15900317 |
| methamphetamine | multiple interactions | ISO | RGD:11314 | 6480464 | TRP53 protein affects the reaction [Methamphetamine affects the expression of SLC6A4 protein] | CTD | PMID:9369336 |
| methamphetamine | affects response to substance | ISO | RGD:11314 | 6480464 | SLC6A4 mRNA affects the susceptibility to Methamphetamine | CTD | PMID:19689456 |
| methamphetamine | affects expression | ISO | RGD:11314 | 6480464 | Methamphetamine affects the expression of SLC6A4 protein | CTD | PMID:11093760 PMID:9369336 |
| methamphetamine | multiple interactions | ISO | RGD:11314 | 6480464 | IL6 protein affects the reaction [Methamphetamine affects the expression of SLC6A4 protein] | CTD | PMID:11093760 |
| methamphetamine | decreases expression | ISO | RGD:732932 | 6480464 | Methamphetamine results in decreased expression of SLC6A4 protein | CTD | PMID:16389202 PMID:18841348 |
| monocrotaline | multiple interactions | ISO | RGD:732932 | 6480464 | Sertraline inhibits the reaction [Monocrotaline results in increased expression of SLC6A4 mRNA] | CTD | PMID:17042913 |
| monocrotaline | increases expression | EXP | | 6480464 | Monocrotaline results in increased expression of SLC6A4 protein | CTD | PMID:17575010 |
| monocrotaline | multiple interactions | EXP | | 6480464 | atorvastatin inhibits the reaction [Monocrotaline results in increased expression of SLC6A4 protein] | CTD | PMID:17575010 |
| monocrotaline | increases expression | ISO | RGD:732932 | 6480464 | Monocrotaline results in increased expression of SLC6A4 mRNA | CTD | PMID:17042913 |
| N-ethyl-N-nitrosourea | increases mutagenesis | EXP | | 6480464 | Ethylnitrosourea results in increased mutagenesis of SLC6A4 gene | CTD | PMID:16495775 |
| nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of SLC6A4 mRNA | CTD | PMID:18835401 |
| nomifensine | multiple interactions | ISO | RGD:732932 | 6480464 | Nomifensine binds to and results in decreased activity of SLC6A4 protein | CTD | PMID:16272152 |
| nortriptyline | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 promoter polymorphism affects the susceptibility to Nortriptyline | CTD | PMID:17018806 |
| nortriptyline | increases response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 protein results in increased susceptibility to Nortriptyline | CTD | PMID:14604448 |
| nortriptyline | decreases response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 gene polymorphism results in decreased susceptibility to Nortriptyline | CTD | PMID:14604448 |
| octopamine | multiple interactions | ISO | RGD:732932 | 6480464 | indatraline inhibits the reaction [SLC6A4 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| paracetamol | increases activity | EXP | | 6480464 | Acetaminophen results in increased activity of SLC6A4 protein | CTD | PMID:10849027 |
| paroxetine | decreases expression | ISO | RGD:732932 | 6480464 | Paroxetine results in decreased expression of SLC6A4 mRNA | CTD | PMID:16055263 |
| paroxetine | multiple interactions | ISO | RGD:732932 | 6480464 | Paroxetine binds to and results in decreased activity of SLC6A4 protein | CTD | PMID:16272152 |
| paroxetine | decreases expression | EXP | | 6480464 | Paroxetine results in decreased expression of SLC6A4 mRNA | CTD | PMID:10575045 |
| paroxetine | affects expression | EXP | | 6480464 | Paroxetine affects the expression of SLC6A4 mRNA | CTD | PMID:10575045 |
| pirinixic acid | decreases expression | ISO | RGD:11314 | 6480464 | pirinixic acid results in decreased expression of SLC6A4 mRNA | CTD | PMID:17426115 |
| pirinixic acid | increases expression | ISO | RGD:11314 | 6480464 | pirinixic acid results in increased expression of SLC6A4 mRNA | CTD | PMID:18301758 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of SLC6A4 mRNA | CTD | PMID:19162173 |
| quercetin | decreases expression | ISO | RGD:732932 | 6480464 | Quercetin results in decreased expression of SLC6A4 mRNA | CTD | PMID:21632981 |
| raloxifene | affects expression | EXP | | 6480464 | Raloxifene affects the expression of SLC6A4 mRNA | CTD | PMID:16079270 |
| raloxifene | multiple interactions | EXP | | 6480464 | Raloxifene inhibits the reaction [estradiol 3-benzoate results in increased expression of SLC6A4 protein] | CTD | PMID:17398000 |
| reserpine | decreases expression | EXP | | 6480464 | Reserpine results in decreased expression of SLC6A4 mRNA | CTD | PMID:10027743 |
| ribavirin | multiple interactions | ISO | RGD:732932 | 6480464 | Ribavirin promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin]; more ... | CTD | PMID:16476009 |
| ribavirin | increases expression | ISO | RGD:732932 | 6480464 | Ribavirin results in increased expression of SLC6A4 mRNA | CTD | PMID:16476009 |
| serotonin | multiple interactions | ISO | RGD:732932 | 6480464 | Lamivudine promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin]; more ... | CTD | PMID:16476009 |
| serotonin | affects binding | ISO | RGD:732932 | 6480464 | Serotonin binds to SLC6A4 protein | CTD | PMID:16272152 |
| serotonin | multiple interactions | EXP | | 6480464 | [Fluoxetine results in decreased expression of SLC6A4 mRNA] which results in decreased abundance of Serotonin | CTD | PMID:16982082 |
| serotonin | increases uptake | ISO | RGD:732932 | 6480464 | SLC6A4 protein results in increased uptake of Serotonin | CTD | PMID:20452607 PMID:16476009 |
| serotonin | increases expression | ISO | RGD:11314 | 6480464 | Serotonin results in increased expression of SLC6A4 mRNA | CTD | PMID:21083617 |
| serotonin | increases uptake | ISO | RGD:11314 | 6480464 | SLC6A4 protein results in increased uptake of Serotonin | CTD | PMID:15972295 |
| serotonin | increases uptake | ISO | RGD:732932 | 6480464 | SLC6A4 protein results in increased uptake of Serotonin | CTD | PMID:16476009 PMID:20452607 |
| serotonin | multiple interactions | ISO | RGD:732932 | 6480464 | [SLC6A4 gene polymorphism results in decreased uptake of Serotonin] which results in decreased susceptibility to Clozapine | CTD | PMID:20452607 |
| serotonin | multiple interactions | ISO | RGD:732932 | 6480464 | SLC6A4 protein promotes the reaction [Serotonin results in increased activity of TAAR1 protein] | CTD | PMID:17234900 |
| serotonin | affects abundance | ISO | RGD:732932 | 6480464 | SLC6A4 gene polymorphism affects the abundance of Serotonin | CTD | PMID:17203304 |
| sertraline | multiple interactions | ISO | RGD:732932 | 6480464 | Sertraline inhibits the reaction [Monocrotaline results in increased expression of SLC6A4 mRNA] | CTD | PMID:17042913 |
| sertraline | increases expression | EXP | | 6480464 | Sertraline results in increased expression of SLC6A4 mRNA | CTD | PMID:18650020 |
| sertraline | decreases expression | EXP | | 6480464 | Sertraline results in decreased expression of SLC6A4 protein | CTD | PMID:12151556 |
| sertraline | multiple interactions | EXP | | 6480464 | [Sertraline results in decreased expression of SLC6A4 protein] which results in decreased metabolism of Serotonin Uptake Inhibitors | CTD | PMID:12151556 |
| sertraline | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 protein affects the susceptibility to Sertraline | CTD | PMID:12955294 |
| sertraline | decreases expression | ISO | RGD:11314 | 6480464 | Sertraline results in decreased expression of SLC6A4 protein | CTD | PMID:18923402 |
| sertraline | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Sertraline] affects the expression of SLC6A4 mRNA; more ... | CTD | PMID:18650020 |
| sertraline | increases response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 promoter polymorphism results in increased susceptibility to Sertraline | CTD | PMID:12955294 |
| simvastatin | increases activity | ISO | RGD:732932 | 6480464 | Simvastatin results in increased activity of SLC6A4 protein | CTD | PMID:15740995 |
| tryptamine | multiple interactions | ISO | RGD:732932 | 6480464 | Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| tyramine | multiple interactions | ISO | RGD:732932 | 6480464 | Citalopram inhibits the reaction [SLC6A4 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| vancomycin | increases expression | ISO | RGD:11314 | 6480464 | Vancomycin results in increased expression of SLC6A4 mRNA | CTD | PMID:18930951 |
| venlafaxine | affects response to substance | ISO | RGD:732932 | 6480464 | SLC6A4 gene polymorphism affects the susceptibility to venlafaxine | CTD | PMID:17503984 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of SLC6A4 mRNA | CTD | PMID:16413754 |
| zinc atom | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Zinc deficiency results in decreased expression of SLC6A4 mRNA] | CTD | PMID:16140947 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of SLC6A4 mRNA | CTD | PMID:16140947 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of SLC6A4 mRNA | CTD | PMID:16413754 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of SLC6A4 mRNA | CTD | PMID:16140947 |
| zinc(0) | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Zinc deficiency results in decreased expression of SLC6A4 mRNA] | CTD | PMID:16140947 |